After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Climb Bio Inc is $125.71M. A total of 0.13 million shares were traded on the day, compared to an average of 331.12K shares.
In the most recent transaction, Pimblett Emily sold 1,235 shares of CLYM for 2.02 per share on Dec 19 ’24. After the transaction, the CHIEF ACCOUNTING OFFICER now owns 11,329 company shares. In a previous transaction on Sep 20 ’24, Pimblett Emily sold 1,191 shares at 8.18 per share. CLYM shares that CHIEF ACCOUNTING OFFICER owns now total 7,564.
Among the insiders who sold shares, Morisset Valerie disposed of 69,005 shares on Jul 22 ’24 at a per-share price of $8.03. This resulted in the EVP, R&D AND CSO holding 31,317 shares of CLYM after the transaction. In another insider transaction, Morisset Valerie sold 60,201 shares at $7.21 per share on Jul 19 ’24. Company shares held by the EVP, R&D AND CSO now total 100,322.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, CLYM has a high of $11.55 and a low of $1.73.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. CLYM’s latest balance sheet shows that the firm has $136.48M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $6.03M in liabilities at the time. Its Book Value Per Share was $3.25, while its Total Shareholder’s Equity was $167.20M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CLYM is Buy with a score of 5.00.
